Get our Free Patent Expiration Newsletter

Serving leading biopharmaceutical companies globally:

Express Scripts

Last Updated: February 21, 2020

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 206551

Email this page to a colleague

See Plans and Pricing

« Back to Dashboard

NDA 206551 describes BIVALIRUDIN, which is a drug marketed by Accord Hlthcare, Apotex, Aurobindo Pharma Ltd, Cipla, Dr Reddys Labs Ltd, Fresenius Kabi Usa, Hospira Inc, Mylan Institutional, Shuangcheng, and Baxter Hlthcare Corp, and is included in eleven NDAs. It is available from ten suppliers. Additional details are available on the BIVALIRUDIN profile page.

The generic ingredient in BIVALIRUDIN is bivalirudin. There are fourteen drug master file entries for this compound. Thirteen suppliers are listed for this compound. Additional details are available on the bivalirudin profile page.
Summary for 206551
Applicant:Accord Hlthcare
Formulation / Manufacturing:see details
Pharmacology for NDA: 206551
Mechanism of ActionThrombin Inhibitors
Suppliers and Packaging for NDA: 206551
Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
BIVALIRUDIN bivalirudin INJECTABLE;INTRAVENOUS 206551 ANDA Accord Healthcare, Inc. 16729-275 16729-275-67 10 VIAL, SINGLE-USE in 1 CARTON (16729-275-67) > 5 mL in 1 VIAL, SINGLE-USE (16729-275-03)

Profile for product number 001

Active Rx/OTC/Discontinued:RXDosage:INJECTABLE;INTRAVENOUSStrength250MG/VIAL
Approval Date:Nov 22, 2017TE:APRLD:No

Complete Access Available with Subscription

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Johnson and Johnson
Harvard Business School

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.